Cosmos Health Inc. revenue by segment COSM

Annual Quarterly

Cosmos Health Inc. splits its revenue into 4 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Wholesale at $59.3 million, 91% of the total.

USD in millions. The percent under a figure is the change from the year before.

Line	FY 2026 Jun 30, 2026	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020	FY 2019 Dec 31, 2019	FY 2018 Dec 31, 2018	FY 2017 Dec 31, 2017	FY 2016 Dec 31, 2016
Revenue	74	65	54	53	50	56	55	40	37	30	7
Wholesale	—	59 +15.0% share 90.9%	52 +1.7% share 94.8%	51 share 95.1%	—	—	—	—	—	—	—
Nutraceuticals And Pharmaceuticals	—	4 +116.7% share 6.5%	2 -14.0% share 3.6%	2 share 4.3%	—	—	—	—	—	—	—
Pharmamanufacturing	—	2 +95.2% share 2.6%	1 +151.0% share 1.6%	0 share 0.6%	—	—	—	—	—	—	—
Other	—	0 share 0.0%	—	—	—	—	—	—	—	—	—

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry: Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)
Listed as: COSM (Nasdaq)
Fiscal year ends: December 31
Incorporated in: NV
Headquarters: Thessaloniki, Greece
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 1474167
Former names: Cosmos Holdings Inc. (until Dec 19, 2022); PRIME ESTATES & DEVELOPMENTS INC (until Jan 3, 2014)

Other Wholesale-Drugs, Proprietaries & Druggists' Sundries companies

All 11 Wholesale-Drugs, Proprietaries & Druggists' Sundries companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.